Michel van Harten

Circassia Ltd. develops medicines for allergic and auto-immune diseases. The company was founded by Anthony Barrington Kay and Mark Larché on December 29, 1998 and is headquartered in Oxford, the United Kingdom.

Part of GSK Plc, Sterling Winthrop, Inc. is a company that specializes in cameras and duplicating machines. The company is based in Rochester, NY. Sterling Winthrop was acquired by GSK Plc from Eastman Kodak Co. on November 03, 1994 for $2,930 million.

Janssen Vaccines & Prevention BV manufactures and supplies biopharmaceutical products. The company was founded in 2000 and is headquartered in Leiden, the Netherlands.

Part of Novartis AG, Sandoz Ltd. is a British company that develops, produces and markets medicines. The company is based in Camberley, UK and was founded in 1981.

Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland.

EQT Partners BV operates as a financial holding company with interests in providing investments. The company was founded on July 3, 2012 and is headquartered in Schiphol, the Netherlands.

Part of Lifexx SA, Immodulon Therapeutics Ltd. is a late-stage clinical biotechnology company based in Uxbridge, UK. Immodulon is developing a highly differentiated cancer immunotherapy approach that primes the patient’s own innate immune system with the aim to significantly enhance the efficacy of a broad range of anti-cancer therapies, including chemotherapy and checkpoint inhibitors. The British company is developing imm-101, a heat-killed mycobacterium obuense, as a broad-spectrum immunomodulatory agent with the potential to treat a range of difficult-to-treat tumors including those considered to be immunologically “ cold, ” such as pancreatic cancer. Immodulon's imm-101 based immunotherapy complements other cancer therapies, including immune checkpoint inhibitors and chemotherapy. The company is focused on developing safe and effective immunotherapy treatments. The company was founded in 2007 by Charles Akle, John L. Stanford. Gertjan Bartlema has been the CEO of the company since 2022.

Founded in 1998, Kyowa Kirin Ltd. is a British pharmaceutical company that develops, manufactures, and distributes pharmaceutical products. Part of Kirin Holdings Co., Ltd., the company is based in London, UK.

Zambon Nederland BV operates as a pharmaceutical company. The company was founded in 1906 and is headquartered in Amersfoort, the Netherlands.

ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom.

riskmethods GmbH develops and provides Software-as-a-Service (SaaS), cloud-based supply chain risk management solution on small and medium enterprises (SMEs), and large businesses in all industries. The firm offers a comprehensive supply chain risk management software to identify risks along global supply chains, assess risk impact, and implement action plans. It also provides supply chain visualization, risk scorecard, comprehensive analyses, early warning system, and impact validator. The company was founded by Heiko Schwarz and Rolf Zimmer in October 2012 and is headquartered in Munich, Germany.

Forcare Holding BV provides software products and services for healthcare. Its products include ForIndex, ForView, ForConnect, ForAudit, ForShare and ForStore. The firm specializes in cross-enterprise document sharing, integrating the healthcare enterprise, health information exchange, security and access control, cross-enterprise document workflow and standards-based interoperability. The company was founded by Harm-Jan Wessels, Mark Sinke and Andries Hamster in January 2006 and is headquartered in Zeist, the Netherlands.

Koolen Participações Ltda. (Koolen Participações) is a venture capital firm founded in 2013 by Koolen Kees. The firm is headquartered in Brazil.

Screenpoint Medical BV provides medical services. The company was founded by Michael Brady and Nico Karssemeijer in May 2014 and is headquartered in Nijmegen, the Netherlands.

Part of Doctolib SAS, Siilo BV is a secure medical messenger platform designed for healthcare professionals. The company is based in Amsterdam, Netherlands. Siilo Messenger allows easy exchange between medical professionals without risking patient data security. Siilo complies with GDPR and international security standards to protect patient data, ensure privacy, and protect personal messages, files, and photos. Siilo Messenger and Siilo Connect change internal communication in modern healthcare and promote collaboration across medical institutions. The Dutch company was founded in 2016 by Arvind Rao, Joost Bruggeman, Jan-Joost Rueb, Onno Bakker. Joost Bruggeman has been the CEO since 2016. Siilo was acquired by Doctolib SAS on March 02, 2023.

Xyall BV engages in the provision of automated tissue dissection solution. The company was founded by Guido du Pree and Hans van Wijngaarden in August 2018 and is headquartered in Eindhoven, the Netherlands.

Leyden Laboratories B.V. is a biotechnology company based in Amsterdam, Netherlands. Leyden Labs aims to protect humanity from known and future viruses by targeting commonalities of viral families. The Dutch company has developed a portfolio of accessible intranasal product candidates that may provide people with the freedom to immediately protect themselves from and prevent the spread of many strains of respiratory viruses, including ones in the influenza and coronavirus families. The company's energetic team of world-renowned biotechnology veterans and fresh talent is dedicated to thinking differently to free humanity from the burden of respiratory viruses. Leyden Labs is backed with $200m by blue-chip investors Casdin Capital, GV (formerly Google Ventures), F-Prime Capital, Byers Capital/Brook Byers, SoftBank Investment Advisers, Invus, and Bluebird Ventures. The company was founded in June 2020 by Koenraad Wiedhaup, Jaap Goudsmit, Domenico Valerio, and Ronald H. P. Brus, with Koenraad Wiedhaup serving as the CEO since incorporation.